Differences in Opioid Overdose Mortality Rates Among Middle-Aged Adults by Race/Ethnicity and Sex, 1999-2018

The types of opioids abused in the United States have changed from prescription opioids to heroin to fentanyl. However, the types of opioids abused may differ by demographic factors, especially among middle-aged adults. We examined national trends in opioid overdose mortality rates among middle-aged...

Full description

Saved in:
Bibliographic Details
Published in:Public health reports (1974) Vol. 136; no. 2; p. 192
Main Authors: Hoopsick, Rachel A, Homish, Gregory G, Leonard, Kenneth E
Format: Journal Article
Language:English
Published: United States 01.03.2021
Subjects:
ISSN:1468-2877, 1468-2877
Online Access:Get more information
Tags: Add Tag
No Tags, Be the first to tag this record!
Abstract The types of opioids abused in the United States have changed from prescription opioids to heroin to fentanyl. However, the types of opioids abused may differ by demographic factors, especially among middle-aged adults. We examined national trends in opioid overdose mortality rates among middle-aged adults by race/ethnicity and sex. Using 1999-2018 data from the Centers for Disease Control and Prevention Wide-ranging ONline Data for Epidemiologic Research database, we examined overdose mortality rates per 100 000 population in 2018 among adults aged 45-64 that involved natural and semisynthetic opioids, heroin, synthetic opioids (excluding methadone), and methadone. We tested for significant differences in mortality rates by race/ethnicity and sex. We plotted drug-specific trends by race/ethnicity and sex from 1999 to 2018. In 2018, non-Hispanic White adults had the highest rates per 100 000 population of natural and semisynthetic overdose mortality (men: 8.7; women: 7.9; < .001), and non-Hispanic Black adults had the highest rates of heroin (men: 17.7; women: 5.4; < .001) and synthetic opioid (men: 36.0; women: 11.2; < .001) overdose mortality. Men had significantly higher overdose mortality rates than women did for deaths involving natural and semisynthetic opioids, heroin, and synthetic opioids, but not methadone. From 1999 to 2018, mortality rates increased sharply for heroin and synthetic opioids, increased modestly for natural and semisynthetic opioids, and decreased for methadone. The greatest increases were among non-Hispanic Black men for heroin overdose (3.3 in 1999 to 17.7 in 2018) and synthetic opioid overdose (0.1 in 1999 to 36.0 in 2018). Policy making should consider unique subgroup risks and alternative trajectories of opioid use other than people being prescribed opioids, developing opioid use disorder, subsequently moving to heroin, and then to fentanyl.
AbstractList The types of opioids abused in the United States have changed from prescription opioids to heroin to fentanyl. However, the types of opioids abused may differ by demographic factors, especially among middle-aged adults. We examined national trends in opioid overdose mortality rates among middle-aged adults by race/ethnicity and sex. Using 1999-2018 data from the Centers for Disease Control and Prevention Wide-ranging ONline Data for Epidemiologic Research database, we examined overdose mortality rates per 100 000 population in 2018 among adults aged 45-64 that involved natural and semisynthetic opioids, heroin, synthetic opioids (excluding methadone), and methadone. We tested for significant differences in mortality rates by race/ethnicity and sex. We plotted drug-specific trends by race/ethnicity and sex from 1999 to 2018. In 2018, non-Hispanic White adults had the highest rates per 100 000 population of natural and semisynthetic overdose mortality (men: 8.7; women: 7.9; < .001), and non-Hispanic Black adults had the highest rates of heroin (men: 17.7; women: 5.4; < .001) and synthetic opioid (men: 36.0; women: 11.2; < .001) overdose mortality. Men had significantly higher overdose mortality rates than women did for deaths involving natural and semisynthetic opioids, heroin, and synthetic opioids, but not methadone. From 1999 to 2018, mortality rates increased sharply for heroin and synthetic opioids, increased modestly for natural and semisynthetic opioids, and decreased for methadone. The greatest increases were among non-Hispanic Black men for heroin overdose (3.3 in 1999 to 17.7 in 2018) and synthetic opioid overdose (0.1 in 1999 to 36.0 in 2018). Policy making should consider unique subgroup risks and alternative trajectories of opioid use other than people being prescribed opioids, developing opioid use disorder, subsequently moving to heroin, and then to fentanyl.
The types of opioids abused in the United States have changed from prescription opioids to heroin to fentanyl. However, the types of opioids abused may differ by demographic factors, especially among middle-aged adults. We examined national trends in opioid overdose mortality rates among middle-aged adults by race/ethnicity and sex.OBJECTIVESThe types of opioids abused in the United States have changed from prescription opioids to heroin to fentanyl. However, the types of opioids abused may differ by demographic factors, especially among middle-aged adults. We examined national trends in opioid overdose mortality rates among middle-aged adults by race/ethnicity and sex.Using 1999-2018 data from the Centers for Disease Control and Prevention Wide-ranging ONline Data for Epidemiologic Research database, we examined overdose mortality rates per 100 000 population in 2018 among adults aged 45-64 that involved natural and semisynthetic opioids, heroin, synthetic opioids (excluding methadone), and methadone. We tested for significant differences in mortality rates by race/ethnicity and sex. We plotted drug-specific trends by race/ethnicity and sex from 1999 to 2018.METHODSUsing 1999-2018 data from the Centers for Disease Control and Prevention Wide-ranging ONline Data for Epidemiologic Research database, we examined overdose mortality rates per 100 000 population in 2018 among adults aged 45-64 that involved natural and semisynthetic opioids, heroin, synthetic opioids (excluding methadone), and methadone. We tested for significant differences in mortality rates by race/ethnicity and sex. We plotted drug-specific trends by race/ethnicity and sex from 1999 to 2018.In 2018, non-Hispanic White adults had the highest rates per 100 000 population of natural and semisynthetic overdose mortality (men: 8.7; women: 7.9; P < .001), and non-Hispanic Black adults had the highest rates of heroin (men: 17.7; women: 5.4; P < .001) and synthetic opioid (men: 36.0; women: 11.2; P < .001) overdose mortality. Men had significantly higher overdose mortality rates than women did for deaths involving natural and semisynthetic opioids, heroin, and synthetic opioids, but not methadone. From 1999 to 2018, mortality rates increased sharply for heroin and synthetic opioids, increased modestly for natural and semisynthetic opioids, and decreased for methadone. The greatest increases were among non-Hispanic Black men for heroin overdose (3.3 in 1999 to 17.7 in 2018) and synthetic opioid overdose (0.1 in 1999 to 36.0 in 2018).RESULTSIn 2018, non-Hispanic White adults had the highest rates per 100 000 population of natural and semisynthetic overdose mortality (men: 8.7; women: 7.9; P < .001), and non-Hispanic Black adults had the highest rates of heroin (men: 17.7; women: 5.4; P < .001) and synthetic opioid (men: 36.0; women: 11.2; P < .001) overdose mortality. Men had significantly higher overdose mortality rates than women did for deaths involving natural and semisynthetic opioids, heroin, and synthetic opioids, but not methadone. From 1999 to 2018, mortality rates increased sharply for heroin and synthetic opioids, increased modestly for natural and semisynthetic opioids, and decreased for methadone. The greatest increases were among non-Hispanic Black men for heroin overdose (3.3 in 1999 to 17.7 in 2018) and synthetic opioid overdose (0.1 in 1999 to 36.0 in 2018).Policy making should consider unique subgroup risks and alternative trajectories of opioid use other than people being prescribed opioids, developing opioid use disorder, subsequently moving to heroin, and then to fentanyl.CONCLUSIONSPolicy making should consider unique subgroup risks and alternative trajectories of opioid use other than people being prescribed opioids, developing opioid use disorder, subsequently moving to heroin, and then to fentanyl.
Author Homish, Gregory G
Leonard, Kenneth E
Hoopsick, Rachel A
Author_xml – sequence: 1
  givenname: Rachel A
  orcidid: 0000-0001-5992-9007
  surname: Hoopsick
  fullname: Hoopsick, Rachel A
  organization: 12292 Department of Family Medicine, Jacobs School of Medicine and Biomedical Sciences, University at Buffalo, The State University of New York, Buffalo, NY, USA
– sequence: 2
  givenname: Gregory G
  surname: Homish
  fullname: Homish, Gregory G
  organization: 12292 Department of Community Health and Health Behavior, School of Public Health and Professions, University at Buffalo, The State University of New York, Buffalo, NY, USA
– sequence: 3
  givenname: Kenneth E
  surname: Leonard
  fullname: Leonard, Kenneth E
  organization: 12292 Department of Psychiatry, Jacobs School of Medicine and Biomedical Sciences, University at Buffalo, The State University of New York, Buffalo, NY, USA
BackLink https://www.ncbi.nlm.nih.gov/pubmed/33211981$$D View this record in MEDLINE/PubMed
BookMark eNpNkElPwzAUhC1URBe4c0I-ciDUWxznGJWySK0qQe-RY78Uo8QpcYLovycVRWIuM4dvnvRmika-8YDQNSX3lCbJnBDOeSxSRlKpFJFnaEKFVBFTSTL6l8doGsIHGcQov0BjzhmlqaITVD24soQWvIGAncebvWucxZsvaG0TAK-bttOV6w74VXcDktWN3-G1s7aCKNuBxZntqy7g4kgYmC-7d-_MsaC9xW_wfYdpmqYRI1RdovNSVwGuTj5D28fldvEcrTZPL4tsFRkhWRepmMYKaEGKlBuugZRKmUQxk0IihSEFjUsOgpnhmVJIw6VlQpPYcFEIYdkM3f6e3bfNZw-hy2sXDFSV9tD0IWdCcjpMEcsBvTmhfVGDzfetq3V7yP8GYj8a_Wb5
CitedBy_id crossref_primary_10_1177_00220426221121121
crossref_primary_10_1016_j_drugalcdep_2025_112834
crossref_primary_10_1177_00333549221091785
crossref_primary_10_1146_annurev_criminol_030421_040140
crossref_primary_10_2105_AJPH_2024_307659
crossref_primary_10_1111_dar_13832
crossref_primary_10_1007_s40615_023_01877_y
crossref_primary_10_1016_j_josat_2023_208986
crossref_primary_10_1186_s12889_025_23375_y
crossref_primary_10_1016_j_drugalcdep_2022_109668
crossref_primary_10_1016_j_drugalcdep_2022_109309
crossref_primary_10_1016_j_ssresearch_2022_102818
crossref_primary_10_1080_15332640_2024_2331108
crossref_primary_10_1177_29767342241243309
crossref_primary_10_1186_s12954_025_01191_2
crossref_primary_10_1016_j_japh_2021_04_020
crossref_primary_10_1016_j_jnma_2022_03_004
crossref_primary_10_1016_j_jbi_2023_104443
crossref_primary_10_1177_29767342251323065
crossref_primary_10_1016_j_drugalcdep_2023_110947
crossref_primary_10_1177_00027162231154348
crossref_primary_10_1186_s13584_024_00598_9
crossref_primary_10_1016_j_drugalcdep_2023_109836
crossref_primary_10_1016_j_josat_2023_209077
crossref_primary_10_1016_j_apgeog_2023_102977
crossref_primary_10_1016_j_drugalcdep_2024_111293
crossref_primary_10_1186_s12889_023_17563_x
crossref_primary_10_1007_s40615_023_01555_z
crossref_primary_10_1080_02791072_2024_2395494
crossref_primary_10_1177_15271544231164323
crossref_primary_10_1097_AJP_0000000000001266
crossref_primary_10_1016_j_socscimed_2025_117947
crossref_primary_10_1016_S2215_0366_23_00119_0
crossref_primary_10_1111_ajad_13638
crossref_primary_10_1177_00333549221074390
crossref_primary_10_1093_aje_kwae094
crossref_primary_10_3389_fphar_2023_1241578
crossref_primary_10_1016_j_drugalcdep_2023_110955
crossref_primary_10_1186_s13011_022_00457_3
crossref_primary_10_1016_j_lana_2022_100218
crossref_primary_10_1186_s12889_022_13298_3
crossref_primary_10_2147_SAR_S482717
crossref_primary_10_1186_s13011_022_00499_7
crossref_primary_10_1007_s11469_024_01310_3
crossref_primary_10_5498_wjp_v14_i6_760
crossref_primary_10_1186_s13011_024_00627_5
crossref_primary_10_2105_AJPH_2021_306431
crossref_primary_10_3389_fphar_2025_1654791
crossref_primary_10_1016_j_josat_2023_209171
crossref_primary_10_1080_09687637_2025_2487448
crossref_primary_10_1016_j_drugalcdep_2023_109859
crossref_primary_10_1016_j_socscimed_2025_118132
crossref_primary_10_1186_s12954_023_00915_6
crossref_primary_10_1080_10826084_2025_2549496
crossref_primary_10_1007_s11469_024_01306_z
crossref_primary_10_1080_07853890_2024_2322051
crossref_primary_10_1080_1533256X_2022_2103982
ContentType Journal Article
DBID CGR
CUY
CVF
ECM
EIF
NPM
7X8
DOI 10.1177/0033354920968806
DatabaseName Medline
MEDLINE
MEDLINE (Ovid)
MEDLINE
MEDLINE
PubMed
MEDLINE - Academic
DatabaseTitle MEDLINE
Medline Complete
MEDLINE with Full Text
PubMed
MEDLINE (Ovid)
MEDLINE - Academic
DatabaseTitleList MEDLINE
MEDLINE - Academic
Database_xml – sequence: 1
  dbid: NPM
  name: PubMed
  url: http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed
  sourceTypes: Index Database
– sequence: 2
  dbid: 7X8
  name: MEDLINE - Academic
  url: https://search.proquest.com/medline
  sourceTypes: Aggregation Database
DeliveryMethod no_fulltext_linktorsrc
Discipline Public Health
EISSN 1468-2877
ExternalDocumentID 33211981
Genre Research Support, U.S. Gov't, P.H.S
Journal Article
Research Support, N.I.H., Extramural
GeographicLocations United States
GeographicLocations_xml – name: United States
GrantInformation_xml – fundername: NIDA NIH HHS
  grantid: R01 DA034072
– fundername: NCATS NIH HHS
  grantid: UL1 TR001412
GroupedDBID ---
--K
-TM
-~X
..I
.55
0R~
0ZK
123
1B1
1KJ
29P
2KS
2WC
3O-
53G
54M
5RE
5VS
76W
7K8
85S
8R4
8R5
96U
AABMB
AACMV
AADUE
AAEWN
AAFWJ
AAGLT
AAIKC
AAJPV
AAMNW
AANEX
AAPII
AAQFI
AAQXI
AARDL
AARIX
AATAA
AAWTL
ABAWP
ABAWQ
ABBHK
ABCCA
ABCJG
ABEIX
ABFNE
ABFWQ
ABIDT
ABJNI
ABKRH
ABLUO
ABPNF
ABPPZ
ABQDR
ABQIJ
ABQXT
ABRHV
ABUJY
ABWJO
ABXSQ
ACARO
ACBMB
ACDIW
ACDSZ
ACDXX
ACFEJ
ACGFO
ACGFS
ACGOD
ACHJO
ACHQT
ACJER
ACKOT
ACNCT
ACOFE
ACOXC
ACROE
ACSIQ
ACUAV
ACUIR
ACXKE
ACXMB
ADBBV
ADEBD
ADEYR
ADGDL
ADRRZ
ADUKH
ADULT
ADVBO
AECGH
AEEHM
AEGXH
AEGZQ
AELLO
AENEX
AEPTA
AEQLS
AESZF
AEUPB
AEWDL
AEWHI
AEXNY
AFAZI
AFEET
AFKRG
AFMOU
AFQAA
AFRAH
AFUIA
AGKLV
AGNAY
AGNHF
AGWFA
AHDMH
AHMBA
AIAGR
AJGYC
AJUXI
AJUZI
AJVBE
AJXAJ
AKBRZ
ALKWR
ALMA_UNASSIGNED_HOLDINGS
AMCVQ
ANDLU
AOIJS
ARTOV
ASUFR
AS~
AUTPY
AYAKG
BAWUL
BBRGL
BCR
BDDNI
BES
BEYMZ
BKIIM
BKOMP
BLC
BPACV
BR6
CAG
CFDXU
CGR
COF
CS3
CUY
CVF
DC-
DC.
DIK
DOPDO
DU5
DV7
EBS
ECM
EIF
EIHBH
EJD
EX3
F5P
F8P
FAC
FAS
FHBDP
FJW
GIFXF
GOZPB
GROUPED_SAGE_PREMIER_JOURNAL_COLLECTION
GRPMH
GX1
H13
HVGLF
HYE
IHE
IPSME
J8X
JAA
JAAYA
JBMMH
JBZCM
JENOY
JHFFW
JKQEH
JLEZI
JLXEF
JPL
JST
K.F
KOO
L7B
LBL
LSO
LXL
LXN
LXY
M41
MVM
NHB
NPM
NQ-
O9-
OK1
OMK
OVD
P2P
PCD
PEA
PQQKQ
PRG
Q.-
Q2X
RIG
RNI
ROL
RPM
RPZ
RWL
RZO
SA0
SASJQ
SAUOL
SCNPE
SFC
SFH
SHG
SJN
SPV
TAE
TEORI
TN5
TR2
UHB
UKR
UNMZH
UXK
W2D
WH7
WOQ
WOW
X7M
XOL
XZL
Y4B
YOC
YR5
YRT
YSK
YYP
YZZ
Z0Y
ZGI
ZONMY
ZPPRI
ZRKOI
~KM
~X8
~ZZ
7X8
AJHME
ID FETCH-LOGICAL-c462t-85158e1b0b93c3ae0f88c782c9e764c0b15f3e42c213f46c36d24a05c34b44d2
IEDL.DBID 7X8
ISICitedReferencesCount 69
ISICitedReferencesURI http://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=Summon&SrcAuth=ProQuest&DestLinkType=CitingArticles&DestApp=WOS_CPL&KeyUT=000600603000001&url=https%3A%2F%2Fcvtisr.summon.serialssolutions.com%2F%23%21%2Fsearch%3Fho%3Df%26include.ft.matches%3Dt%26l%3Dnull%26q%3D
ISSN 1468-2877
IngestDate Sun Sep 28 01:34:40 EDT 2025
Mon Jul 21 05:54:54 EDT 2025
IsDoiOpenAccess false
IsOpenAccess true
IsPeerReviewed true
IsScholarly true
Issue 2
Keywords mortality
White
opioid overdose
Black or African American
Hispanic or Latino
Language English
LinkModel DirectLink
MergedId FETCHMERGED-LOGICAL-c462t-85158e1b0b93c3ae0f88c782c9e764c0b15f3e42c213f46c36d24a05c34b44d2
Notes ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
ORCID 0000-0001-5992-9007
OpenAccessLink https://journals.sagepub.com/doi/pdf/10.1177/0033354920968806
PMID 33211981
PQID 2463100256
PQPubID 23479
ParticipantIDs proquest_miscellaneous_2463100256
pubmed_primary_33211981
PublicationCentury 2000
PublicationDate 2021-03-01
PublicationDateYYYYMMDD 2021-03-01
PublicationDate_xml – month: 03
  year: 2021
  text: 2021-03-01
  day: 01
PublicationDecade 2020
PublicationPlace United States
PublicationPlace_xml – name: United States
PublicationTitle Public health reports (1974)
PublicationTitleAlternate Public Health Rep
PublicationYear 2021
SSID ssj0000213
Score 2.539248
Snippet The types of opioids abused in the United States have changed from prescription opioids to heroin to fentanyl. However, the types of opioids abused may differ...
SourceID proquest
pubmed
SourceType Aggregation Database
Index Database
StartPage 192
SubjectTerms Ethnicity
Female
Heroin - toxicity
Humans
Male
Middle Aged
Opiate Overdose - epidemiology
Opiate Overdose - ethnology
Opiate Overdose - mortality
Racial Groups
Sex Distribution
Synthetic Drugs - toxicity
United States - epidemiology
Title Differences in Opioid Overdose Mortality Rates Among Middle-Aged Adults by Race/Ethnicity and Sex, 1999-2018
URI https://www.ncbi.nlm.nih.gov/pubmed/33211981
https://www.proquest.com/docview/2463100256
Volume 136
WOSCitedRecordID wos000600603000001&url=https%3A%2F%2Fcvtisr.summon.serialssolutions.com%2F%23%21%2Fsearch%3Fho%3Df%26include.ft.matches%3Dt%26l%3Dnull%26q%3D
hasFullText
inHoldings 1
isFullTextHit
isPrint
link http://cvtisr.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwpV1LS8NAEF7UehDE96O-WMGjS9PsZrM5SdEWL32gPfQWktldDUhSTRV_vrNJSk-C4CXkkA1hMpn5MjP7fYTcSKO5hjRikdaKiUTjWRJxBphLQmVk6NlabCIcjdRsFk2aglvZjFUuY2IVqHUBrkbe8YV0tWjM0Hfzd-ZUo1x3tZHQWCctjlDGeXU4W7GFY_7iy91F-GcQrtqUlYYZd-xkCOHRheXvALNKNIPd_z7iHtlpICbt1T6xT9ZMfkC26_ocrbcdHZK3h0YZBeMEzXI6nmdFpukYPVsXpaHDCpYjRKdPDo3SnhMlosOqnMF6L0bTnmPuKGnqrgDT6S9e8wzcgiTX9Nl839KKewBTvzoi00F_ev_IGuUFBkL6C4YwLFCmm3ppxIEnxrNKAWIJiEwoBXhpN7DcCB_QwFZI4FL7IvEC4CIVQvvHZCMvcnNKaGC18a3mEViOMRnxPN7ZUynCqsTwANrkemnLGB3bdSuS3BSfZbyyZpuc1C8kntcMHDHnjphOdc_-sPqcbPluDqWaG7sgLYuftbkkm_C1yMqPq8pj8DiaDH8ApJDHvg
linkProvider ProQuest
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Differences+in+Opioid+Overdose+Mortality+Rates+Among+Middle-Aged+Adults+by+Race%2FEthnicity+and+Sex%2C+1999-2018&rft.jtitle=Public+health+reports+%281974%29&rft.au=Hoopsick%2C+Rachel+A&rft.au=Homish%2C+Gregory+G&rft.au=Leonard%2C+Kenneth+E&rft.date=2021-03-01&rft.eissn=1468-2877&rft.volume=136&rft.issue=2&rft.spage=192&rft_id=info:doi/10.1177%2F0033354920968806&rft_id=info%3Apmid%2F33211981&rft_id=info%3Apmid%2F33211981&rft.externalDocID=33211981
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=1468-2877&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=1468-2877&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=1468-2877&client=summon